Clinical Trial Update: Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing how HDM1005 influences gastric emptying and the pharmacokinetics of metformin, atorvastatin, warfarin, and digoxin in overweight/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• DIGOXIN (Digoxin)
• Warfarin (warfarin)
• atorvastatin (atorvastatin)
• metformin (metformin)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Overweight, Obesity | Phase 1 | Status: NOT_YET_RECRUITING